Moderna, Inc.MRNANASDAQ
Loading
SG&A Expense Growth Recovery in ProgressRecovering
Percentile Rank11
Year-over-Year Change
Year-over-year SG&A expense growth
Percentile
P11
Within normal range
vs 5Y Ago
-0.2x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | -13.29% |
| 2024 | -24.21% |
| 2023 | 36.84% |
| 2022 | 99.65% |
| 2021 | 201.17% |
| 2020 | 71.75% |
| 2019 | 16.31% |
| 2018 | 45.63% |
| 2017 | 12.66% |
| 2016 | 0.00% |